The activation of ECS was shown to affect several cell survival pathways in breast cancer, such as epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), casepase3 and nuclear factor kappa B (NF-κB) p65 [10, 12, 13]. The gene discussed is EGF; the disease is breast carcinoma.